The Discounted Cash Flow (DCF) valuation of Amedisys Inc (AMED) is 107.62 USD. With the latest stock price at 100.99 USD, the upside of Amedisys Inc based on DCF is 6.6%.
Based on the latest price of 100.99 USD and our DCF valuation, Amedisys Inc (AMED) is a buy. buying Amedisys stocks now will result in a potential gain of 6.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.5% | 7.4% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 73.98 - 204.39 | 107.62 |
| Upside | -26.7% - 102.4% | 6.6% |